Search

Your search keyword '"Rasko DA"' showing total 210 results

Search Constraints

Start Over You searched for: Author "Rasko DA" Remove constraint Author: "Rasko DA"
210 results on '"Rasko DA"'

Search Results

51. Comparative genomic analysis and molecular examination of the diversity of enterotoxigenic Escherichia coli isolates from Chile.

52. Examination of 388 Staphylococcus aureus Isolates from Intensive Care Unit Patients.

53. Shigella flexneri Adherence Factor Expression in In Vivo -Like Conditions.

54. The Complete Genome of the Atypical Enteropathogenic Escherichia coli Archetype Isolate E110019 Highlights a Role for Plasmids in Dissemination of the Type III Secreted Effector EspT.

55. Future-Proofing Your Microbiology Resource Announcements Genome Assembly for Reproducibility and Clarity.

56. Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection.

57. Genetic changes associated with the temporal shift in invasive non-typhoidal Salmonella serovars in Bamako Mali.

58. Genomic and Phenotypic Diversity among Ten Laboratory Isolates of Pseudomonas aeruginosa PAO1.

59. Genome and Functional Characterization of Colonization Factor Antigen I- and CS6-Encoding Heat-Stable Enterotoxin-Only Enterotoxigenic Escherichia coli Reveals Lineage and Geographic Variation.

60. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS).

61. Cumulative acquisition of pathogenicity islands has shaped virulence potential and contributed to the emergence of LEE-negative Shiga toxin-producing Escherichia coli strains.

62. Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain.

63. Temporal Variability of Escherichia coli Diversity in the Gastrointestinal Tracts of Tanzanian Children with and without Exposure to Antibiotics.

64. Coli Surface Antigen 26 Acts as an Adherence Determinant of Enterotoxigenic Escherichia coli and Is Cross-Recognized by Anti-CS20 Antibodies.

65. Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development.

66. Targeted enrichment outperforms other enrichment techniques and enables more multi-species RNA-Seq analyses.

67. A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge.

68. Responses of the Human Gut Escherichia coli Population to Pathogen and Antibiotic Disturbances.

69. Diversity among bla KPC -containing plasmids in Escherichia coli and other bacterial species isolated from the same patients.

70. Phosphotyrosine-Mediated Regulation of Enterohemorrhagic Escherichia coli Virulence.

71. Draft Genome Sequences of bla KPC -Containing Enterobacter aerogenes, Citrobacter freundii, and Citrobacter koseri Strains.

72. Structural modification of LPS in colistin-resistant, KPC-producing Klebsiella pneumoniae.

73. Characterization of a Large Antibiotic Resistance Plasmid Found in Enteropathogenic Escherichia coli Strain B171 and Its Relatedness to Plasmids of Diverse E. coli and Shigella Strains.

74. The AraC Negative Regulator family modulates the activity of histone-like proteins in pathogenic bacteria.

75. Locus of Adhesion and Autoaggregation (LAA), a pathogenicity island present in emerging Shiga Toxin-producing Escherichia coli strains.

76. Transcriptional Variation of Diverse Enteropathogenic Escherichia coli Isolates under Virulence-Inducing Conditions.

77. Aligner optimization increases accuracy and decreases compute times in multi-species sequence data.

78. Comparative genomics and transcriptomics of Escherichia coli isolates carrying virulence factors of both enteropathogenic and enterotoxigenic E. coli.

79. Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology.

80. Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts.

81. Changes in microbiome during and after travellers' diarrhea: what we know and what we do not.

82. Chaperone-Usher Pili Loci of Colonization Factor-Negative Human Enterotoxigenic Escherichia coli .

83. The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1.

84. Survival of the Fittest: How Bacterial Pathogens Utilize Bile To Enhance Infection.

85. Use of Comparative Genomics To Characterize the Diversity of Acinetobacter baumannii Surveillance Isolates in a Health Care Institution.

86. Draft Genome Sequence of Biocontrol Agent Bacillus cereus UW85.

87. An integrated genomic and transcriptomic survey of mucormycosis-causing fungi.

88. Investigating the Relatedness of Enteroinvasive Escherichia coli to Other E. coli and Shigella Isolates by Using Comparative Genomics.

89. Hybrid Shiga Toxin-Producing and Enterotoxigenic Escherichia sp. Cryptic Lineage 1 Strain 7v Harbors a Hybrid Plasmid.

90. Genome diversity of Shigella boydii.

91. Genomic diversity of EPEC associated with clinical presentations of differing severity.

92. Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.

93. Diarrhea, bacteremia and multiorgan dysfunction due to an extraintestinal pathogenic Escherichia coli strain with enteropathogenic E. coli genes.

94. Comparative Genomics Provides Insight into the Diversity of the Attaching and Effacing Escherichia coli Virulence Plasmids.

95. Characterization of the pathogenome and phylogenomic classification of enteropathogenic Escherichia coli of the O157:non-H7 serotypes.

96. RNA-Seq analysis of isolate- and growth phase-specific differences in the global transcriptomes of enteropathogenic Escherichia coli prototype isolates.

97. Examination of the Enterotoxigenic Escherichia coli Population Structure during Human Infection.

98. Phylogenetically typing bacterial strains from partial SNP genotypes observed from direct sequencing of clinical specimen metagenomic data.

99. Bacterial Factors Associated with Lethal Outcome of Enteropathogenic Escherichia coli Infection: Genomic Case-Control Studies.

100. Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.

Catalog

Books, media, physical & digital resources